Julianne Bruno's most recent trade in CRISPR Therapeutics AG was a trade of 3,750 Restricted Stock Units done . Disclosure was reported to the exchange on March 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2025 | 3,750 | 11,250 | - | - | Restricted Stock Units | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2025 | 3,750 | 12,258 (0%) | 0% | - | Common Shares | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.23 per share. | 20 Mar 2025 | 1,714 | 10,544 (0%) | 0% | 41.2 | 70,668 | Common Shares |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 36,666 | 36,666 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 27,500 | 27,500 | - | - | Restricted Stock Units | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,399 | 9,461 (0%) | 0% | - | Common Shares | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,399 | 4,796 | - | - | Restricted Stock Units | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 42.42 per share. | 10 Mar 2025 | 1,198 | 8,263 (0%) | 0% | 42.4 | 50,819 | Common Shares |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 435 | 8,698 (0%) | 0% | - | Common Shares | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 435 | 0 | - | - | Restricted Stock Units | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.32 per share. | 10 Mar 2025 | 190 | 8,508 (0%) | 0% | 43.3 | 8,231 | Common Shares |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 650 | 7,395 (0%) | 0% | - | Common Shares | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 650 | 650 | - | - | Restricted Stock Units | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 52.80 per share. | 18 Feb 2025 | 333 | 7,062 (0%) | 0% | 52.8 | 17,582 | Common Shares |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | 16 Oct 2024 | 18,333 | 18,333 | - | - | Stock Option (Right to Buy) | ||
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | 20 Jun 2024 | 7,000 | 10,111 (0%) | 0% | - | Common Shares | ||
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | 20 Jun 2024 | 7,000 | 0 | - | - | Restricted Stock Units | ||
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | 20 Jun 2024 | 3,366 | 6,745 (0%) | 0% | 56.1 | 188,799 | Common Shares | |
| CRISPR Therapeutics AG | Julianne Bruno | Chief Operating Officer | 23 May 2024 | 20,000 | 20,000 | - | - | Restricted Stock Units |